首页> 美国卫生研究院文献>Scientific Reports >The prognostic significance of MRI-detected extramural venous invasion mesorectal extension and lymph node status in clinical T3 mid-low rectal cancer
【2h】

The prognostic significance of MRI-detected extramural venous invasion mesorectal extension and lymph node status in clinical T3 mid-low rectal cancer

机译:MRI检测的壁外静脉浸润直肠系膜延伸和淋巴结状况对临床T3中下直肠癌的预后意义

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The purpose of this study was to evaluate the prognostic significance of the magnetic resonance imaging-detected extramural venous invasion (MR-EMVI), the depth of mesorectal extension (MR-DME), and lymph node status (MR-LN) in clinical T3 mid-low rectal cancer. One hundred and forty-six patients with clinical T3 mid-low rectal cancer underwent curative surgery were identified. Pretreatment high-resolution MRI was independently reviewed by two experienced radiologists to evaluate MR-EMVI score (0–4), MR-DME (≤4 mm or >4 mm), and MR-LN (positive or negative). The Cox-multivariate regression analysis revealed that the MR-EMVI was the only independent prognostic factor that correlated with overall 3-year disease-free survival (DFS) (p = 0.01). The survival analysis showed that patients with positive MR-EMVI, MR-DME > 4 mm, and positive MR-LN had a poorer prognosis in the overall 3-year DFS (HR 3.557, 95% CI 2.028 to 13.32, p < 0.01; HR 3.744, 95% CI:1.165 to 5.992, p = 0.002; HR 2.946, 95% CI: 1.386 to 6.699, p < 0.01). By combining MR-EMVI with MR-DME or MR-LN, the prognostic significance was more remarkable. Our study suggested that the MR-EMVI, MR-DME, and MR-LN were the important prognostic factors for patients with clinical T3 mid-low rectal cancer and the MR-EMVI was an independent prognostic factor.
机译:这项研究的目的是评估磁共振成像检测壁外静脉浸润(MR-EMVI),直肠系膜延伸深度(MR-DME)和淋巴结状态(MR-LN)在临床T3中的预后意义中低位直肠癌。确定了146例临床T3中低位直肠癌患者接受了根治性手术。两名资深放射医师对治疗前的高分辨率MRI进行了独立审查,以评估MR-EMVI评分(0–4),MR-DME(≤4µmm或> 4µmm)和MR-LN(阳性或阴性)。 Cox多变量回归分析显示,MR-EMVI是唯一与总体3年无病生存(DFS)相关的独立预后因素(p = 0.01)。生存分析表明,MR-EMVI阳性,MR-DME≥4mm,MR-LN阳性的患者在整个3年DFS中的预后较差(HR 3.557,95%CI 2.028至13.32,p <0.01; HR 3.744,95%CI:1.165至5.992,p = 0.002; HR 2.946,95%CI:1.386至6.699,p <0.01)。通过将MR-EMVI与MR-DME或MR-LN结合使用,其预后意义更加显着。我们的研究表明,MR-EMVI,MR-DME和MR-LN是临床T3中低位直肠癌患者的重要预后因素,而MR-EMVI是独立的预后因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号